2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Diabetes & Metabolism Journal

• Publication date

  2025-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4093/dmj.2025.0469PMID 40631460PMCID 12270580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness and Safety of Oral Quadruple Combination Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

  2025cited by this paper
• Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial

  2024cited by this paper
• Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study

  2024cited by this paper
• The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysis

  2024cited by this paper
• Nutritional Status, Dietary Intake, and Nutrition-Related Interventions Among Older Adults With Type 1 Diabetes: A Systematic Review and Call for More Evidence Toward Clinical Guidelines.

  2024cited by this paper
• Medical Assistant Health Coaching for Type 2 Diabetes in Primary Care: Results From a Pragmatic Cluster Randomized Controlled Trial.

  2024cited by this paper
• Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).

  2024cited by this paper
• Kenyan adults with type 2 diabetes mellitus (T2DM) increase diabetic knowledge and self-efficacy and decrease hemoglobina1c levels post-educational program

  2024cited by this paper
• Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.

  2024cited by this paper
• Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity

  2024cited by this paper
• Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.

  2024cited by this paper
• EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

  2024cited by this paper
• The Michigan Men’s Diabetes Project Randomized Clinical Control Trial: A Pilot/Feasibility Study of a Peer-Led Diabetes Self-Management and Support Intervention for Black Men With Type 2 Diabetes

  2024cited by this paper
• Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials

  2024cited by this paper
• Disease-Tailored Brief Intervention for Alcohol Use Among Youths With Chronic Medical Conditions

  2024cited by this paper
• Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

  2024cited by this paper
• Interventions to reduce sedentary behaviour in adults with type 2 diabetes: A systematic review and meta-analysis

  2024cited by this paper
• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.

  2024cited by this paper
• 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.

  2024cited by this paper
• 14. Children and Adolescents: Standards of Care in Diabetes-2025.

  2024cited by this paper
• 7. Diabetes Technology: Standards of Care in Diabetes-2025.

  2024cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents

  2024cited by this paper
• Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.

  2024cited by this paper
• The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta‐analysis

  2024cited by this paper
• THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES.

  2024cited by this paper
• Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.

  2024cited by this paper
• The effectiveness of diabetes self-management education intervention on glycaemic control and cardiometabolic risk in adults with type 2 diabetes in low- and middle-income countries: A systematic review and meta-analysis

  2024cited by this paper
• Smartphone Applications to Prevent type 2 Diabetes: a systematic review and meta-analysis.

  2024cited by this paper
• Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.

  2024cited by this paper
• KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

  2024cited by this paper
• Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

  2024cited by this paper
• 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.

  2024cited by this paper
• Long-term lifestyle intervention can reduce the development of type 2 diabetes mellitus in subjects with prediabetes: A systematic review and meta-analysis.

  2024cited by this paper
• A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

  2024cited by this paper
• Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial.

  2024cited by this paper
• Enhancing Diabetes Care through a Mobile Application: A Randomized Clinical Trial on Integrating Physical and Mental Health among Disadvantaged Individuals

  2024cited by this paper
• Influence of a diet and/or exercise intervention on long‐term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study

  2024cited by this paper
• Lessons learned from a peer-supported diabetes education program in two dissimilar Mayan communities

  2024cited by this paper
• Defining “low-carb” in the scientific literature: A scoping review of clinical studies

  2024cited by this paper
• Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials

  2023cited by this paper
• Fibrosis Progression Rate in Biopsy-proven Nonalcoholic Fatty Liver Disease among People with Diabetes versus People without Diabetes: A Multicenter Study.

  2023cited by this paper
• Effect of non-supplemented low-protein diet on the initiation of renal replacement therapy in stage 4 and 5 chronic kidney disease: a retrospective multicenter cohort study in Japan.

  2023cited by this paper
• Protein restriction in adults with chronic kidney disease, with or without diabetes: Integrated Diabetes and Endocrine Academy (IDEA) consensus statement for Indian patients.

  2023cited by this paper
• Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

  2023cited by this paper
• A randomized controlled trial for evaluating an occupational therapy self management intervention in adults with type 2 diabetes

  2023cited by this paper
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

  2023cited by this paper
• A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

  2023cited by this paper
• A multisociety Delphi consensus statement on new fatty liver disease nomenclature

  2023cited by this paper
• Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

  2023cited by this paper
• Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.

  2023cited by this paper
• Effect of Dietary Approaches on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review with Network Meta-Analysis of Randomized Trials

  2023cited by this paper
• Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

  2023cited by this paper
• The effect of personalized intelligent digital systems for self-care training on type II diabetes: a systematic review and meta-analysis of clinical trials

  2023cited by this paper
• A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials

  2023cited by this paper
• Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: a randomised trial.

  2023cited by this paper
• Interrupting prolonged sitting with frequent short bouts of light‐intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT‐LESS randomised controlled trial

  2023cited by this paper
• Novel low-sodium salt formulations combined with Chinese modified DASH diet for reducing blood pressure in patients with hypertension and type 2 diabetes: a clinical trial

  2023cited by this paper
• The Effectiveness of Medical Nutrition Therapy Provided by a Dietitian in Adults with Prediabetes: A Systematic Review and Meta-Analysis.

  2023cited by this paper
• Educational attainment affects the diagnostic time in type 2 diabetes mellitus and the mortality risk of those enrolled in the diabetes pay-for-performance program.

  2023cited by this paper
• Comparison of the Efficacy of Metformin and Lifestyle Modification for the Primary Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

  2023cited by this paper
• Effect of hypoglycemia on cognitive performance in older patients with diabetes: A meta-analysis.

  2023cited by this paper
• Dietary fiber intake and all-cause and cause-specific mortality: An updated systematic review and meta-analysis of prospective cohort studies.

  2023cited by this paper
• The effects of a plate model on the remission and need for hypoglycemic drugs of newly diagnosed type 2 diabetes in China: A randomized trial

  2023cited by this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Health and cancer risks associated with low levels of alcohol consumption

  2023cited by this paper
• 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.

  2023cited by this paper
• 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024.

  2023cited by this paper
• 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist

  2023cited by this paper
• 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study

  2023cited by this paper
• Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.

  2023cited by this paper
• Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial.

  2023cited by this paper
• Effect of Mini-Dose Ready-to-Use Liquid Glucagon on Preventing Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes

  2023cited by this paper
• Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide

  2023cited by this paper
• Dietary Factors and All-Cause Mortality in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Prospective Observational Studies.

  2023cited by this paper
• Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus

  2023cited by this paper
• Treatment of Obesity and Metabolic-Associated Fatty Liver Disease with a Diet or Orlistat: A Randomized Controlled Trial.

  2023cited by this paper
• An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial.

  2023cited by this paper
• Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study.

  2023cited by this paper
• Consumption of sugar sweetened beverages, artificially sweetened beverages and fruit juices and risk of type 2 diabetes, hypertension, cardiovascular disease, and mortality: A meta-analysis

  2023cited by this paper
• Cost-Effectiveness Analysis of the Culturally Developed Diabetes Self-Management Education and Support Program among Type 2 Diabetes Mellitus Patients in Iraq

  2023cited by this paper
• Evidence-based European recommendations for the dietary management of diabetes

  2023cited by this paper
• Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.

  2023cited by this paper
• Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies

  2023cited by this paper
• 2022 National Standards for Diabetes Self-Management Education and Support.

  2022cited by this paper
• Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial

  2022cited by this paper
• Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies

  2022cited by this paper
• Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: A randomized controlled trial.

  2022cited by this paper
• 2022 National Standards for Diabetes Self-Management Education and Support

  2022cited by this paper
• Low-doses aspirin in the primary prevention of cardiovascular disease in patients with diabetes: Meta-analysis stratified by baseline cardiovascular risk.

  2022cited by this paper
• Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine

  2022cited by this paper
• The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases

  2022cited by this paper
• Saline Compared to Balanced Crystalloid in Patients With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2022cited by this paper
• Effects of a Patient-Centered Intervention to Reduce Alcohol Use Among Youth With Chronic Medical Conditions.

  2022cited by this paper
• Updated Meta-Analysis of Studies from 2011 to 2021 Comparing the Effectiveness of Intermittent Energy Restriction and Continuous Energy Restriction

  2022cited by this paper
• Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

  2022cited by this paper
• Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.

  2022cited by this paper
• Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

  2022cited by this paper
• The effectiveness of patient-centered care vs. usual care in type 2 diabetes self-management: A systematic review and meta-analysis

  2022cited by this paper

• Identification of sex-specific sarcopenia risk groups among older adults using decision tree modeling: a cross-sectional study based on the Korean National Health and Nutrition Examination Survey

  2026cites this paper
• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

  2026cites this paper
• The relationship between fasting blood glucose, glycated hemoglobin, fructosamine, and depression in patients with type 2 diabetes mellitus in South Korea: a secondary analysis of the Korea National Health and Nutrition Examination Survey VIII-2 (2020) data

  2026influential citation
• 2025 Clinical Practice Guidelines for Diabetes: Pharmacological Treatment of Type 2 Diabetes

  2025cites this paper
• 2025 Clinical Practice Guidelines for Diabetes

  2025cites this paper
• 2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management

  2025cites this paper
• Lifestyle prescriptions for diabetes management in primary care: a narrative review

  2025influential citation
• Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM).

  2025cites this paper
• Defining Severe Diabetes Mellitus: A Consensus Framework for Grading and Staging Diabetes Based on Pathophysiology and Complications

  2025influential citation
• Type 2 diabetes in children and adolescents: key considerations based on the 2025 Korea Diabetes Association clinical practice guidelines for diabetes management

  2025cites this paper
• From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications

  2025cites this paper
• Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes

  2025cites this paper
• Real-World Evidence of Long-Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years.

  2025cites this paper
• Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy.

  2025cites this paper
• Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

  2025cites this paper
• New Therapeutic Paradigm for Diabetic Kidney Disease Focused on Finerenone

  2025cites this paper
• Digital Healthcare and Diabetic Retinopathy: Patient Experience Innovation and Support for Diabetes Care

  2025cites this paper
• Management of Diabetic Retinopathy: An Integrated Approach Through Systemic Diabetes Treatment

  2025cites this paper
• Preventing End-Stage Kidney Disease in Older Adults with Type 2 Diabetes Mellitus: Optimal Blood Pressure Targets

  2025influential citation
• Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension

  2025influential citation
• Clinical Implications of Real-Time Continuous Glucose Monitoring in Hospitalized Patients

  2025cites this paper
• Songwon Lecture 2025 Postpartum Glucose Intolerance in Women with a History of Gestational Diabetes Mellitus: An In-Depth Review

  year unknowncites this paper
• S M Nazmuz Sakib's Holistic Neuromuscular Rehabilitation with Mindfulness, Rhythmic Movement, Emotional Release, and Adaptive Mobility (HNR-MERAM)

  year unknowncites this paper